| 注册
首页|期刊导航|国际神经病学神经外科学杂志|遗传性痉挛性截瘫11型发病机制研究进展

遗传性痉挛性截瘫11型发病机制研究进展

徐浩然 刘小民

国际神经病学神经外科学杂志2025,Vol.52Issue(6):82-86,5.
国际神经病学神经外科学杂志2025,Vol.52Issue(6):82-86,5.DOI:10.16636/j.cnki.jinn.1673-2642.2025.06.012

遗传性痉挛性截瘫11型发病机制研究进展

Research advances in the pathogenesis of hereditary spastic paraplegia type 11

徐浩然 1刘小民2

作者信息

  • 1. 山东第二医科大学临床医学院,山东 潍坊 261000
  • 2. 山东第一医科大学第一附属医院(山东省千佛山医院)神经内科,山东 济南 250014
  • 折叠

摘要

Abstract

Hereditary spastic paraplegia type 11(SPG11)is the most common subtype of autosomal recessive hereditary spastic paraplegia(HSP)and is caused by mutations in the SPG11 gene,with the clinical features of progressive spastic paraparesis,cognitive decline,dysarthria,peripheral neuropathy,muscle atrophy,sphincter dysfunction,and ataxia.Typical neuroimaging features include thinning of the corpus callosum and periventricular white matter abnormalities.Molecular genetic research in recent years has shown that the pathogenesis of SPG11 involves at least seven interrelated mechanisms,i.e.,neuroimmune and inflammatory responses,impaired cholesterol transport,abnormal mitochondrial function and dynamics,defects in axonal transport,disruption of the autophagy-lysosome pathway,neurodevelopmental disorders,and metabolic imbalance in the hypothalamus.These mechanisms not only clarify the pathogenic basis of SPG11,but also provide important theoretical support for the development of targeted therapeutic strategies for SPG11-associated HSP.This article reviews these mechanisms and explore future therapeutic directions.

关键词

遗传性痉挛性截瘫/SPG11基因/发病机制

Key words

hereditary spastic paraplegia/SPG11 gene/pathogenesis

分类

医药卫生

引用本文复制引用

徐浩然,刘小民..遗传性痉挛性截瘫11型发病机制研究进展[J].国际神经病学神经外科学杂志,2025,52(6):82-86,5.

基金项目

山东省自然科学基金项目(ZR2021MH059). (ZR2021MH059)

国际神经病学神经外科学杂志

1673-2642

访问量0
|
下载量0
段落导航相关论文